Literature DB >> 9032120

Upregulation of neuropeptides and neuropeptide receptors in a murine model of immune inflammation in lung parenchyma.

H B Kaltreider1, S Ichikawa, P K Byrd, D A Ingram, J L Kishiyama, S P Sreedharan, M L Warnock, J M Beck, E J Goetzl.   

Abstract

The lung is richly supplied with peptidergic nerves that store and secrete substance P (SP), vasoactive intestinal peptide (VIP), and other neuropeptides known to potently modulate leukocyte function in vitro and airway inflammation in vivo. To investigate and characterize neuromodulation of immune responses compartmentalized in lung parenchyma, neuropeptide release and expression of neuropeptide receptors were studied in lungs of antigen-primed C57BL/6 mice after intratracheal challenge with sheep erythrocytes. The concentrations of cytokines in bronchoalveolar lavage (BAL) fluid rose early and peaked on day 1 for interleukin (IL)-2, interferon gamma, and IL-10; days 1 to 2 for IL-6; and day 3 for IL-4, whereas the total number and different types of leukocytes in BAL fluid peaked subsequently on days 4 to 6 after i.t. antigen challenge. Immunoreactive SP and VIP in BAL fluid increased maximally to nanomolar concentrations on days 1 to 3 and 2 to 7, respectively in lungs undergoing immune responses. The high-affinity SP receptor (NK-1 R), and VIP types I (VIPR1) and II (VIPR2) receptors were localized by immunohistochemistry to surface membranes of mononuclear leukocytes and granulocytes in perivascular, peribronchiolar, and alveolar inflammatory infiltrates during immune responses. As quantified by reverse transcription-polymerase chain reaction, significant increases were observed in levels of BAL lymphocyte mRNA encoding NK-1 R (days 2 to 4), VIPR1 (days 2 to 4), and VIPR2 (days 4 to 6), and in alveolar macrophage mRNA encoding NK-1 R (days 2 to 6) and VIPR1 (days 2 to 4), but not VIPR2. Systemic treatment of mice with a selective, nonpeptide NK-1 R antagonist reduced significantly the total numbers of leukocytes, lymphocytes, and granulocytes retrieved by BAL on day 5 of the pulmonary immune response. The results indicate that SP and VIP are secreted locally during pulmonary immune responses, and are recognized by leukocytes infiltrating lung tissue, and thus their interaction may regulate the recruitment and functions of immune cells in lung parenchyma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9032120     DOI: 10.1165/ajrcmb.16.2.9032120

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  22 in total

1.  Subset-specific reductions in lung lymphocyte accumulation following intratracheal antigen challenge in endothelial selectin-deficient mice.

Authors:  Jeffrey L Curtis; Joanne Sonstein; Ronald A Craig; Jill C Todt; Randall N Knibbs; Timothy Polak; Daniel C Bullard; Lloyd M Stoolman
Journal:  J Immunol       Date:  2002-09-01       Impact factor: 5.422

2.  Translocation of Bax and Bid to mitochondria, endoplasmic reticulum and nuclear envelope: possible control points in apoptosis.

Authors:  Barbara Gajkowska; Urszula Wojewódzka; Joanna Gajda
Journal:  J Mol Histol       Date:  2004-01       Impact factor: 2.611

Review 3.  Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1.

Authors:  Anthony J Harmar; Jan Fahrenkrug; Illana Gozes; Marc Laburthe; Victor May; Joseph R Pisegna; David Vaudry; Hubert Vaudry; James A Waschek; Sami I Said
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

4.  Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice.

Authors:  R A Tripp; D Moore; J Winter; L J Anderson
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  CCR2 and CCR6, but not endothelial selectins, mediate the accumulation of immature dendritic cells within the lungs of mice in response to particulate antigen.

Authors:  John J Osterholzer; Theresa Ames; Timothy Polak; Joanne Sonstein; Bethany B Moore; Stephen W Chensue; Galen B Toews; Jeffrey L Curtis
Journal:  J Immunol       Date:  2005-07-15       Impact factor: 5.422

6.  Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC(2) receptor for vasoactive intestinal peptide.

Authors:  E J Goetzl; J K Voice; S Shen; G Dorsam; Y Kong; K M West; C F Morrison; A J Harmar
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

7.  Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor.

Authors:  Carmen Martinez; Catalina Abad; Mario Delgado; Alicia Arranz; Maria G Juarranz; Nieves Rodriguez-Henche; Philippe Brabet; Javier Leceta; Rosa P Gomariz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

8.  Significance of Conversation between Mast Cells and Nerves.

Authors:  Hanneke Pm van der Kleij; John Bienenstock
Journal:  Allergy Asthma Clin Immunol       Date:  2005-06-15       Impact factor: 3.406

9.  Upregulation of neurokinin-1 receptor expression in the lungs of patients with sarcoidosis.

Authors:  Terence M O'Connor; Joseph O'Connell; Darren I O'Brien; Michael W Bennett; Triona Goode; Louise Burke; Charles P Bredin; Fergus Shanahan
Journal:  J Clin Immunol       Date:  2003-09       Impact factor: 8.317

10.  Brain-derived neurotrophic factor (BDNF) contributes to neuronal dysfunction in a model of allergic airway inflammation.

Authors:  Armin Braun; Marek Lommatzsch; Ulrich Neuhaus-Steinmetz; David Quarcoo; Thomas Glaab; Gerard P McGregor; Axel Fischer; Harald Renz
Journal:  Br J Pharmacol       Date:  2004-01-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.